Citigroup Inc Mustang Bio, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.32 - $8.27 $410 - $10,618	-1,284 Reduced 93.79%	85 $0
Q3 2022 Nov 10, 2022	SELL	$0.46 - $7.2 $639 - $10,008	-1,390 Reduced 50.38%	1,369 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.58 - $1.13 $1,423 - $2,774	-2,455 Reduced 47.08%	2,759 $2,000
Q1 2022 May 12, 2022	SELL	$0.73 - $1.81 $12,245 - $30,362	-16,775 Reduced 76.29%	5,214 $5,000
Q4 2021 Feb 10, 2022	BUY	$1.66 - $2.64 $23,173 - $36,854	13,960 Added 173.87%	21,989 $37,000
Q3 2021 Nov 10, 2021	BUY	$2.58 - $3.36 $20,714 - $26,977	8,029 New	8,029 $22,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.